GENESIS TECH LIMITED has a total of 37 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BAKSH DOLORES, BLASTICON BIOTECH FORSCHUNG and VIVALIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Israel | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Organic fine chemistry | |
#6 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Ahlfors Jan-Eric | 29 |
#2 | El-Ayoubi Rouwayda | 8 |
#3 | Elayoubi Rouwayda | 5 |
#4 | Mekouar Khalid | 4 |
#5 | Ahlfors Jan-Eric W | 3 |
#6 | Mani Sarathi | 2 |
#7 | Ahlfors Jan Eric | 1 |
#8 | Sarathi Mani | 1 |
Publication | Filing date | Title |
---|---|---|
EP3472625A1 | Automated cell processing systems and methods | |
EP3472321A2 | Crispr-cas system, materials and methods | |
US2017029783A1 | Methods for reprogramming cells and uses thereof | |
US2015273112A1 | Autogenic living scaffolds and living tissue matrices: methods and uses thereof | |
AU2013237667A1 | Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products | |
EP2697246A1 | Selective cysteine protease inhibitors and uses thereof | |
EP3567103A1 | Methods for reprogramming cells and uses thereof | |
AU2006305989A1 | Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products |